EVI sends seasonal greetings to all our partners, colleagues, friends past and present.

European Commission supports project that will define a new vision for vaccine research in Europe and proposes strategies for its achievement

Brussels, 20th December 2013

EVI sends sincere thanks to speakers, chairs, facilitators and to all participants, who helped to make the 2013 RdV a memorable event.  We hope to see you again this year.

Final agendaList of participants

At its recent Board meeting, 5 December 2013, the Board approved Alister Craig, Liverpool School of Tropical Medicine as Chair of EVI SAC.

Two Vice Chairs were also approved: Long time member, Ingileif Jónsdóttir, Landspitali University Hospital and Faculty of Medicine, University of Iceland, and James Robertson, retired, who joined SAC this year.

The new Chair of the Board is Clemens Kocken, Biomedical Primate Research Centre

European Commission supports EDUFLUVAC project to develop an innovative vaccine against influenza.

14 November 2013 sees the launch by EVI and WHO and the Malaria Vaccine Funders Group of the updated Malaria Vaccine Technology Roadmap 

Link to full text in The Lancet

See also following links:WHO  WHO ImmunizationWHO Intl. Malaria

New global strategy for prevention of death and disease from malaria 

Heidelberg/Washington, 14 November 2013

Update of the Malaria Vaccine Technology Roadmap aims for effective malaria vaccines by 2030

Medical Research Council (MRC) announces the captioned two week course to be held at the Uganda Virus Research Institute (UVRI), Entebbe.

Course details

The EVI Annual Report 2012 is just one click away.

An inter-active user friendly version on a USB stick will be widely distributed during the coming days.  Would you like to receive a copy, but are not sure whether you are on the mailing list, please

Professor Tom Ottenhoff, member of the steering committee of the TuBerclosis Vaccine Initiative (TBVI), received the Eijkman Medal 2013 on 16 October at the Dutch Royal Tropical Institute

EVI round table on "The Challenge of Developing a Pregnancy Associated Malaria Vaccine" was a great success with many comments and an active discussion among the 70-80 participants.